Table 5.
Treatment used: (single drug or combinations) Oral 5-ASA ±, 5-ASAenemas or supp., prednisone, azathioprine, corticosteroids enemas. (Infliximab was used in 2 cases) | |
Surgical interference (yes/no) | 4/131 |
Relapses (mean ± SD) | 1.514 ± 1.575 |
Relapses (median/minimum/maximum) | 1/0/10 |
Malignant transformation | 1 |
Mean ESR 1st hour (mean ± SD) | 36.37 ± 24.73 |
CRP (positive/negative/not done) | 39/34/60 |
ANCA (positive/negative/not done) | 12/28/95 |
ASCA (positive/negative/not done) | 8/31/96 |
Pathological findings included: Vascular congestion, Crypt abscesses, Mucin depletion, Cellular infiltrate, Cryptitis, Crypt branching | |
Pathology (diagnostic/suggestive/non conclusive) | 78/43/14 |
Mean Hemoglobin concentration, gm/dL (mean ± SD) | 11.2 ± 2.8 |
Mean PLT count (mean ± SD) | 335428.6 ± 140119.1 |
Mean TLC (mean ± SD) | 8875 ± 4059.67 |
ASA: Aminosalicylic acid; CRP: C-reactive protein; ANCA: Anti-neutrophil cytoplasmic antibodies; ASCA: Anti-Saccharomyces cerevisiae antibodies.